LSD and psilocybin have been associated with significant positive changes in clinical measures of depression, anxiety, and psychiatric disorders such as OCD and addiction.1-4 An emerging property of psychedelics, however, is their anti-inflammatory potential. Recent studies have found evidence for the role of the 5-HT2A receptor in the inflammatory response, showing that activation of this…


Previous articleMEC Announces Submission of Listing Statement to the CSE in Coordination with Albert Labs RTO
Next articleCOMPASS Pathways and Kings College London publish cognition results from COMP360 psilocybin study in healthy volunteers